Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Accumulated Expenses (2010 - 2026)

Opko Health's (OPK) quarterly Accumulated Expenses came in at $77.8 million in Q2 2026, down 14.13% on a YoY basis from $90.6 million in Q2 2025, and down 6.85% quarter-over-quarter from $83.5 million in Q1 2026.

Analysis

Opko Health (OPK) Accumulated Expenses (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Accumulated Expenses for 17 consecutive years, with $77.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses fell 14.13% year-over-year to $77.8 million; the trailing twelve-month figure through Jun 2026 stood at $77.8 million (down 14.13% YoY), and the FY2025 full-year result was $84.4 million, down 28.69% from the prior year.
  • Accumulated Expenses retreated to $77.8 million in Q2 2026 per OPK's latest filing, from $83.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $157.3 million in Q1 2022 and bottomed at $77.8 million in Q2 2026.
  • Historically, Accumulated Expenses has averaged $102.9 million across 5 years, with a median of $96.9 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Accumulated Expenses sank 49.21% in 2022, then jumped 32.95% in 2024.
  • Over 5 years, Accumulated Expenses stood at $98.3 million in 2022, then decreased by 8.33% to $90.1 million in 2023, then soared by 31.38% to $118.4 million in 2024, then declined by 28.69% to $84.4 million in 2025, then fell by 7.88% to $77.8 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $77.8 million, $83.5 million, and $84.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.76 Mn
Mar 31, 2026 83.48 Mn
Dec 31, 2025 84.41 Mn
Sep 30, 2025 95.60 Mn
Jun 30, 2025 90.56 Mn
Mar 31, 2025 113.21 Mn
Dec 31, 2024 118.36 Mn
Sep 30, 2024 122.81 Mn
Jun 30, 2024 94.52 Mn
Mar 31, 2024 88.77 Mn
Dec 31, 2023 90.09 Mn
Sep 30, 2023 92.37 Mn
Jun 30, 2023 98.60 Mn
Mar 31, 2023 106.06 Mn
Dec 31, 2022 98.27 Mn
Sep 30, 2022 112.02 Mn
Jun 30, 2022 128.25 Mn
Mar 31, 2022 157.32 Mn
Dec 31, 2021 193.49 Mn
Sep 30, 2021 163.93 Mn
API Access

Opko Health Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OPK&period=max&api_key=YOUR_API_KEY